Back to Screener

Healthcare

Hansa Biopharma AB (publ)(HNSBF)

Live Price

Offline

$2.90

+0.00% today

Window Change

+0.00%

Window

Apr 16, 2026 β†’ Jun 23, 2026

Market Cap
$2.21B
Revenue Growth
+29.7%
EPS Growth
+49.0%
Dividend Yield
0.0%
Sparse coverage

Historical coverage is still filling in

This 1Y daily history view is currently sparse. Use it as directional context while we continue backfilling more history.

Coverage: 49 bars Β· Apr 16, 2026 β†’ Jun 23, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Hansa Biopharma AB (publ) (HNSBF) is a Healthcare stock with a market cap of $2.21B and listed on OTC. The stock last traded around $2.90 and up 0.0% across the available one-year price window (Apr 16, 2026 β†’ Jun 23, 2026). Baseline metrics include revenue growth of +29.7%, EPS growth of +49.0%, a dividend yield of 0.0%. What stands out right now is revenue +29.7%, EPS +49.0%, free cash flow +18.6% with operating margin -299.1% and ROIC -60.0%. Valuation already assumes a fairly strong business story at price/sales 11.6. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines HNSBF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

HNSBF vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

HNSBF

β€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

HNSBF Max Drawdown

0.00%

Trailing 1Y

SPY Max Drawdown

β€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for HNSBF and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

πŸ“… Last reportedApr 23, 2026
PeriodB/MEPSEPS Ξ”RevenueRev Ξ”Report
β€”
Apr 23, 26
β€”
Est -0.16
β€”
β€”
Est 5166.3B
β€”
Apr 23
β€”
Feb 11, 26
βœ—
-0.18
Est -0.17
-2.8%
8223.2B
Est 4365.0B
+88.4%
Feb 11
β€”
Oct 30, 25
βœ—
-0.19
Est -0.18
-0.8%
3262.1B
Est 38831.2B
-91.6%
Oct 30
β€”
Jul 17, 25
βœ—
-0.26
Est -0.17
-51.2%
5132.8B
Est 63175.7B
-91.9%
Jul 17
β€”
Apr 24, 25
βœ“
-0.05
Est -0.27
+79.4%
6627.7B
Est 70450.0B
-90.6%
Apr 24
β€”
Feb 6, 25
βœ—
-0.37
Est -0.18
-105.8%
2910.3B
Est 77751.0B
-96.3%
Feb 6
β€”
Oct 17, 24
βœ“
-0.16
Est -0.24
+32.9%
4690.4B
Est 5312.2B
-11.7%
Oct 17
β€”
Jul 18, 24
βœ—
-0.31
Est -0.26
-19.7%
3248.4B
Est 5095.6B
-36.3%
Jul 18
β€”
Apr 18, 24
βœ—
-0.38
Est -0.32
-18.4%
5161.4B
Est 5046.9B
+2.3%
Apr 18
β€”
Mar 4, 24
βœ“
-0.23
Est -0.37
+36.3%
4986.3B
Est 4349.1B
+14.7%
Mar 4
β€”
Sep 30, 23
βœ—
-0.43
Est -0.36
-19.7%
2073.1B
Est 3751.4B
-44.7%
Sep 30
β€”
Jun 30, 23
βœ—
-0.44
Est -0.33
-34.9%
3378.0B
Est 3642.6B
-7.3%
Jun 30
β€”
Mar 31, 23
βœ—
-0.38
Est -0.28
-34.6%
2324.6B
Est 3165.1B
-26.6%
Mar 31
β€”
Dec 31, 22
βœ“
-0.31
Est -0.40
+20.4%
3004.2B
Est 2961.6B
+1.4%
Dec 31
β€”
Sep 30, 22
βœ—
-0.31
Est -0.17
-80.8%
5987.0B
Est 2642.5B
+126.6%
Sep 30
β€”
Jun 30, 22
βœ—
-0.37
Est -0.18
-103.5%
2565.8B
Est 1819.5B
+41.0%
Jun 30
β€”
Mar 31, 22
βœ“
-0.33
Est -0.38
+13.5%
3227.3B
Est 1675.5B
+92.6%
Mar 31
β€”
Dec 31, 21
-0.40
Est β€”
β€”
1697.3B
Est β€”
β€”
Dec 31
β€”
Sep 30, 21
-0.38
Est β€”
β€”
563.4B
Est β€”
β€”
Sep 30
β€”
Jun 30, 21
-0.35
Est β€”
β€”
528.6B
Est β€”
β€”
Jun 30
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the market calendar